Theme

Tumor-type
specific Sessions

Session Title

High grade glioma(clinical)

Presentation
No.

Abstract
No.

Lecture title

SpeakerCountry

HGGC-IS-01

SPKR-34

Translating the advancing biology of CNS high-grade gliomas into actual patient benefit Mark Kieran

USA

HGGC-O-02

HGG-01

Entrectinib in recurrent or refractory solid tumors including primary CNS tumors:
updated data in children and adolescents

Giles Robinson

USA

HGGC-O-03

HGG-18

Clinical efficacy of ONC201 in thalamic H3 K27M-mutant glioma

Abed Rahman Kawakibi

USA

HGGC-O-04

HGG-17High-grade glioma in very young children; a single-center 11-year-experience

Moatasem El-ayadi

Egypt

HGGC-P-05

HGG-52

Sustained response to crizotinib monotherapy in an infant with GOPC-ROS1 fusedcongenital hemispheric glioma

Rishi Lulla

USA

HGGC-P-06

HGG-35

Pediatric pleomorphic xanthoastrocytoma with anaplasia treated with surgery andadjuvant chemotherapy: a case series of 3 long-term survivors

Rebecca Ronsley

Canada

HGGC-P-07

HGG-39Clinical characteristics and outcome of patients with radiation-induced glioma

Makoto OhnoJapanHGGC-P-08

HGG-40Exceptional synchronous occurence of a BRAF V600E mutant glioblastoma and a
H3.3K27M mutant diffuse intrinsic pontine glioma : a case report

Emilie De Carli

France

HGGC-P-09

HGG-02Adolescent and young adult (AYA) glioma with BRAF V600E-mutantation

Yui KimuraJapan

HGGC-P-10

HGG-06

Remarkable response to BRAF inhibitor in an infant with Disseminated Diffuse
Leptomeningeal Glioneuronal Tumor (DLGNT)Le Aung

Singapore

HGGC-P-11

HGG-11High-grade gliomas in adolescents and young adults highlight histomoleculardifferences with their adult and paediatric counterparts

Pascale Varlet

France

HGGC-P-12

HGG-44

Defects of mismatch repair proteins in pediatric high grade gliomas

Christine Haberler

Austria

HGGC-P-13

HGG-54

Histological and molecular characterization of high-grade brain tumors secondary tototal body irradiation for hematological malignancies

Evelina Miele

Italy

HGGC-P-14

HGG-14Treatment and prognostic factors for pediatric glioblastomas--The 10 years experiencefrom one single center

Juan LiChina

HGGC-P-15

HGG-42Clinical features and treatment outcome of malignant gliomas in children andadolescentsHajime YonezawaJapan

HGGC-P-16

HGG-24High-grade glioma with a novel fusion gene of VCL-ALK

Shunsuke YamamotoJapan

HGGC-P-17

HGG-05Regression of recurrent glioblastoma after boron neutron capture therapy and chimericHsin-Hung Chen
antigen receptor T-cell therapy in a child

HGGC-P-18

HGG-09First line therapy of pediatric glioblastoma with larotrectinib

Nahla Mobark

Saudi Arabia

HGGC-P-19

HGG-12A case of pediatric spinal high-grade glioma with NTRK1 gene fusion

Tamaki MorisakoJapan

HGGC-P-20

HGG-29A case of circumscribed high-grade astrocytoma with ATRX and CDKN2A/B
alternations who was initially diagnosed as glioblastoma and has 20 years survival

Yusuke KobayashiJapan

HGGC-P-21

HGG-48

ROS1 inhibitor Entrectinib use in relapse/refractory infantile glioblastoma with positive
ROS1 fusion - a case report with promising response

Dennis Tak-Loi Ku

Hong Kong

HGGC-P-22

HGG-43Congenital glioblastoma multiforme: a case report of a rare pediatric brain tumor,
molecular analysis, and review of the literature

Christina AmendUSA

HGGC-P-23

HGG-47

Decreased growth velocity with long term use of BRAFV600e and MEK inhibition in apatient with anaplastic ganglioglioma

Hung Tran

USA

HGGC-P-24

HGG-49A pediatric thalamic high-grade glioma with H3F3A K27M and BRAF V600E doublemutations

Keita TerashimaJapan

HGGC-P-25

HGG-33

Case series of diffuse extra-neural metastasis in H3F3A mutant high grade gliomas clinical, molecular phenotype and literature review

Sana Mohiuddin

USA

HGGC-P-26

HGG-50

Two cases of H3 K27M-mutant diffuse midline glioma of cervical spinal cord

Masae KurohaJapan

HGGC-P-27

HGG-30Analysis of pediatric gliomas in our institute

Kaoru Tamura

JapanTaiwan